Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeEXECUTIVESTiffany Ahlers: New Senior VP at Mycovia

Tiffany Ahlers: New Senior VP at Mycovia

Tiffany Ahlers has been appointed VP at Mycovia Pharmaceuticals. The news was announced today.

In this role, Ms. Ahlers will oversee global commercial operations for the company in addition to supporting business development activities and overall company branding.

“Tiffany’s proven record in leading and managing operations for biopharmaceutical companies will be instrumental as we move toward commercialization of VT-1161 for the treatment of recurrent vulvovaginal candidiasis (RVVC), a disease for which there are no approved treatments in the US,” said Patrick Jordan, Chief Executive Officer of Mycovia. “With Tiffany’s 20 years of cross-functional experience in leading commercial strategy, a global Phase 3 program recruiting ahead of schedule, and an exclusive license agreement with Hengrui Medicine to develop and commercialize VT-1161 in China, Mycovia is building global commercial capabilities in anticipation of launching VT-1161 in 2021. We welcome Tiffany to the team and look forward to working with her as we work to scale our organization into a fully integrated biopharmaceutical company.”

“Joining a company that is paving the path for a potential new treatment paradigm for millions of people living with RVVC and other fungal diseases is a tremendous opportunity,” said Ms. Ahlers. “The Phase 2 data clearly demonstrates VT-1161’s profound efficacy in the treatment of RVVC, and I am thrilled to play a role in translating its clinical potential into commercial reality.”

Ms. Ahlers most recently served as a Senior Vice President at Cello Health Advantage, a boutique market research and consultancy firm, that supports the global pharmaceutical, biotech and health sectors. Previously, she spent almost 10 years at Stallergenes Greer, where she served as Vice President of Marketing and led, developed and managed the daily operations for the US marketing department and the company’s business units. Ms. Ahlers also worked at Cornerstone Therapeutics, which is now Chiesi USA.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy